Keyphrases
Hepatocellular Carcinoma
100%
Molecular Profiling
100%
Cell-free DNA (cfDNA)
100%
ErbB2
75%
ARID1A
50%
Egfr
50%
Circulating Tumor DNA (ctDNA)
50%
B-Raf
50%
Risk Factors
25%
United States
25%
PIK3CA
25%
Targeted Therapy
25%
Blood Samples
25%
Genomic Testing
25%
Clinical Utility
25%
Gene Amplification
25%
Tissue Biopsy
25%
Tumor Protein p53 (TP53)
25%
Hepatitis B
25%
Cyclin-dependent Kinase 6 (CDK6)
25%
Mutant Allele Frequency
25%
Liver Tissue
25%
CCNE1
25%
Non-invasive Strategies
25%
Actionable Alteration
25%
Hepatocellular Carcinoma Risk
25%
Actionable Genomic Alteration
25%
Biochemistry, Genetics and Molecular Biology
Genomics
100%
Epidermal Growth Factor Receptor
66%
Hepatitis B Virus
66%
ARID1A
66%
Circulating Tumor DNA
66%
Myc
66%
Gene Frequency
33%
KRAS
33%
Gene Amplification
33%
Targeted Therapy
33%
Medicine and Dentistry
Hepatocellular Carcinoma
100%
Molecular Profiling
100%
Cell-Free DNA
100%
Epidermal Growth Factor Receptor
40%
Hepatitis B Virus
40%
Circulating Tumor DNA
40%
Targeted Therapy
20%
Hepatitis B
20%
Gene Amplification
20%
Biopsy Technique
20%
Liver Tissue
20%
Gene Frequency
20%
Immunology and Microbiology
Hepatitis B Virus
100%
Hepatitis B
50%
Gene Amplification
50%
Liver Tissue
50%
Gene Frequency
50%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Epidermal Growth Factor Receptor
40%
Hepatitis B Virus
40%
Circulating Tumor DNA
40%
Hepatitis B
20%